<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1007601.ref066">
 <label>66</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Mulder</surname>
   <given-names>SF</given-names>
  </name>, 
  <name>
   <surname>Jacobs</surname>
   <given-names>JF</given-names>
  </name>, 
  <name>
   <surname>Olde Nordkamp</surname>
   <given-names>MA</given-names>
  </name>, 
  <name>
   <surname>Galama</surname>
   <given-names>JM</given-names>
  </name>, 
  <name>
   <surname>Desar</surname>
   <given-names>IM</given-names>
  </name>, 
  <name>
   <surname>Torensma</surname>
   <given-names>R</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccination</article-title>. 
  <source>Clin Cancer Res</source>. 
  <year>2011</year>;
  <volume>17</volume>(
  <issue>13</issue>):
  <fpage>4541</fpage>â€“
  <lpage>9</lpage>. Epub 2011/06/30. 
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-11-0253</pub-id> .
  <?supplied-pmid 21712444?>
  <pub-id pub-id-type="pmid">21712444</pub-id>
 </mixed-citation>
</ref>
